(Health-NewsWire.Net, October 29, 2016 ) About infectious disease testing Infectious diseases are caused by microorganisms such as viruses, bacteria, fungi, and parasites. Infectious diseases are one of the primary contributors to morbidity and mortality worldwide. According to the CDC, in the US there are more than 1.2 million people living with HIV infection and one in eight are unaware about their condition. In 2013, it was estimated that 47,352 Americans were diagnosed with HIV infection and in the same year 26,688 people were diagnosed with AIDS. Early diagnosis and treatment play an important role to prevent the long-term complications of HIV/AIDS. Molecular testing, POCT, and immunodiagnostics are used for the screening and detection the disease. Infectious diseases increasingly threaten public health and contribute significantly to the rising costs of health care.
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=517530
Manufacturers are developing diagnostic tests that can provide results in just a few minutes. For example, Alere developed Alere BinaxNOW Influenza A&B Card, which can detect influenza A & B in 15 minutes.
Technavio's analysts forecast the infectious disease testing market in the US to grow at a CAGR of 5.81% over the period 2014-2019.
Covered in this report The report covers the current scenario and the growth prospects of the infectious disease testing market in the US for the period of 2015-2019. To calculate the market size, we consider the revenue generated from the sales of equipment and consumables from molecular diagnostics, POCT diagnostic devices, and immunodiagnostics, which are used to detect infectious diseases:
The market is segmented based on technology: Molecular diagnostic test POCT Immunodiagnostic test
Read All In Vitro Diagnostics Market Research Reports @ http://www.researchmoz.us/in-vitro-diagnostics-market-reports-28.html
Table of Content
PART 01: Executive summary Highlights PART 02: Scope of the report Market overview Top-vendor offerings PART 03: Market research methodology Research methodology Economic indicators PART 04: Introduction Key market highlights PART 05: Market landscape Market overview PART 06: Infectious disease landscape in the US Reimbursement in US Clinical laboratory improvement amendments (CLIA) waiver from US Food and Drug Administration Five forces analysis PART 07: Market segmentation by technology Molecular diagnostic test POCT for infectious diseases Immunodiagnostic tests PART 08: Market segmentation by application PART 09: Market segmentation by product Equipment Consumables
Contact Us:
Mr. Nachiket Albany NY, United States - 12207 Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free) Email: sales@researchmoz.us Follow us on LinkedIn at: http://bit.ly/1TBmnVG Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com
|